Open an account

ICU Medical

ICUI · NASDAQ

$161.08−$0.16 (−0.10%)TodayMarket closed ·
Prev close $161.24

About ICUI

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.

Employees
13,000
Headquarters
San Clemente, California
Listed
Mar 31, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
icumed.com

ICUI key statistics

Market cap
4.03B
Price-earnings ratio
135.50
Dividend yield
—
Average volume
243.04K
Volume
160.22K
Open price
$161.60
High today
$164.00
Low today
$160.57
52 Week high
$192.85
52 Week low
$113.37

ICU Medical (ICUI) at a glance

As of Oct 20, 2026, ICU Medical (ICUI) shares are priced at $161.08, giving the company a market cap of 4.03B and a price-to-earnings ratio of 135.50.

Today the stock has traded between $160.57 and $164.00. The current price is 0.3% above the day's low and 1.8% below its high.

Volume so far is 160.22K shares, below the average of 243.04K shares a day.

Over the past year ICU Medical has ranged from $113.37 to $192.85, and now sits 60% of the way up that range.

ICU Medical met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $2.37 per share against an estimate of $1.95.

The average analyst price target is $199.48, 23.8% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 9 analystsAvg $199.48
Low
$188.87
Now
$161.08
High
$220.50

ICUI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 26.8% on average.

  1. Q3 FY24: reported $1.59 per share against an estimate of $1.28
  2. Q4 FY24: reported $2.11 per share against an estimate of $1.51
  3. Q1 FY25: reported $1.72 per share against an estimate of $1.31
  4. Q2 FY25: reported $2.10 per share against an estimate of $1.53
  5. Q3 FY25: reported $2.03 per share against an estimate of $1.46
  6. Q4 FY25: reported $1.91 per share against an estimate of $1.73
  7. Q1 FY26: reported $1.97 per share against an estimate of $1.79
  8. Q2 FY26: reported $2.37 per share against an estimate of $1.95

ICUI news

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)

  • Eva Mathew

    EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks

  • Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI

Similar companies

Companies in the same industry as ICU Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.